UTI Mutual Fund

UTI Healthcare Fund - Direct Plan - Growth Option

Equity Scheme - Sectoral/ ThematicDirect planGrowthInception

NAV vs Benchmark

Trailing Returns

Series1Y3Y5Y10YSI
Scheme10.95%27.80%15.10%14.94%16.13%
Benchmark-0.51%13.25%12.00%6.55%88.66%
Excess11.46%14.54%3.10%8.39%-72.53%

Trailing returns are annualized (CAGR) for 3Y / 5Y / 10Y and absolute for 1Y. SI is total return since the first available NAV. Benchmark returns are derived from the scheme's mandated TRI index.

Expense Ratio (TER)

Direct
1.21%
Regular
2.16%

Direct plans have a lower expense ratio because no distributor commission is paid. Regular plans are sold through intermediaries who provide advice.

YieldIQ Fund Score

B
68/ 100
Rule-based composite of returns, risk, cost, and tenure.

Fee impact calculator

What the expense ratio costs over time, and the Direct-vs-Regular plan gap. Pre-filled with this scheme's expense ratios — adjust any input.

No fees
₹3,10,585
Direct plan
₹2,78,616
Regular plan
₹2,55,626
Fee drag · Direct, 10y
₹31,969
Direct keeps more than Regular
₹22,990

Illustrative only — assumes a constant 12% gross return and the expense ratios above held flat; actual returns and fees vary. Direct plans carry no distributor commission. Not advice.

Past performance is not indicative of future returns. Mutual fund investments are subject to market risks; read all scheme-related documents carefully.
UTI Healthcare Fund - Direct Plan - Growth Option — Mutual Fund Analysis | YieldIQ